FMP
Medpace Holdings, Inc.
MEDP
NASDAQ
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
395.93 USD
6.16 (1.56%)
About
ceo
Dr. August James Troendle M.D.
sector
Healthcare
industry
Medical - Diagnostics & Research
website
https://www.medpace.com
exchange
NASDAQ
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, ...
CIK
0001668397
ISIN
US58506Q1094
CUSIP
58506Q109
Address
5375 Medpace Way
Phone
513 579 9911
Country
US
Employee
5,800
IPO Date
Aug 11, 2016
Summary
CIK
0001668397
Exchange
NASDAQ
Industry
Medical - Diagnostic...
Sector
Healthcare
CUSIP
58506Q109
ISIN
US58506Q1094
Country
US
Price
395.93
Beta
1.4
Volume Avg.
277.76k
Market Cap
12.27B
Shares
-
52-Week
197.39-421.0
DCF
372.4
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
40.32
P/B
-
Website
https://www.medpace.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest MEDP News
It looks like there's no news available.
